¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phagocytic dysfunction disorders immunodeficiency"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® acquired immunodeficiency syndrome ÇÑ±Û ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
¼³¸í   
  Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV)¿¡ ÀÇÇÏ¿© ¸é¿ª ¼¼Æ÷°¡ ÆÄ±«µÊÀ¸·Î½á ÀÎüÀÇ ¸é¿ª´É·ÂÀÌ ±Øµµ·Î ÀúÇϵǾ´¿øÃ¼¿¡ ´ëÇÏ¿© ¹«¹æºñ »óÅ¿¡ À̸£´Â º´. ¿¡ÀÌÁî ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â¸ç, 1981³â ¹Ì±¹¿¡¼­ Ã³À½ º¸°íµÇ¾ú´Ù. ÃÖÃÊ °¨¿°À¸·ÎºÎÅÍ Áõ»óÀÌ ³ªÅ¸³ª±â±îÁö´Â Æò±Õ 10³â Á¤µµ °É¸®¸ç »ç¸Á·üÀÌ ´ë´ÜÈ÷ ³ô´Ù. ¼ºÀû Á¢ÃË, ¿À¿° ÁÖ»ç±â »ç¿ë, ¿À¿° Ç÷¾× ¹× Ç÷¾× Á¦Á¦ »ç¿ë, ¿¡ÀÌÁî »ê¸ð·ÎºÎÅÍ ¼öÁ÷°¨¿° µûÀ§¿¡ ÀÇÇÏ¿© °¨¿°µÈ´Ù. °¨¿° ÈÄ Àϰú¼ºÀ¸·Î °¨±â¿Í °°Àº Áõ»óÀ» º¸À̸砹ÙÀÌ·¯½ºÇ÷ÁõÀ¸·Î µÇÁö¸¸ ¹ÙÀÌ·¯½º´Â °¨¼ÒµÇ°í 6~8ÁÖ ÈÄ¿¡´Â Ç×ü°¡ ¾ç¼ºÀ¸·Î µÈ´Ù. 6~10³â Á¤µµÀÇ ¹«ÁõÈļº º¸±Õ±â°£À» Áö³ª¼­ ¿¡ÀÌÁî°ü·ÃÁõÈıº(AIDS related syndrome)À¸·Î µÈ´Ù. ÀúÇ×·ÂÀÇ °¨¼Ò, ¸²ÇÁÀýºñ´ë, Ã¼Áß°¨¼Ò, ¹ß¿­, ¸¸¼º¼³»ç°¡ À̾îÁø´Ù. ±× ÈÄ ¿¡ÀÌÁî·Î µÇ¸ç, ÆóÆ÷ÀÚÃæÆó·Å µîÀÇ ¿øÃ溴, Ä­µð´Ù µîÀÇ Áø±ÕÁõ, Ç츣Æä½º¹ÙÀÌ·¯½º±º µîÀÇ ±âȸ°¨¿°ÀÌ À̾îÁø´Ù. ¶ÇÇÑ Ä«Æ÷½ÃÀ°Á¾, ¸²ÇÁÁ¾ µîÀ» º´¹ßÇØ¼­ »ç¸ÁÇÑ´Ù. ¹ÙÀÌ·¯½ºÀÇ ³úÁ¶Á÷³» Áõ½ÄÀ¸·Î Ä¡¸Å¸¦ ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. HIV-1Àº 10³â°£¿¡ »ç¸Á·üÀÌ 90%, HIV-2´Â 10%ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phagocytic cell
    Æ÷½Ä¼¼Æ÷
  • phagocytic index
    Æ÷½Ä¼¼Æ÷Áö¼ö, ޽ÄÁö¼ö
  • acquired immunodeficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human immunodeficiency virus-2
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º2
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´
  • constitutional hepatic dysfunction
    üÁú°£±â´ÉÀÌ»ó
  • dysfunction
    ±â´ÉÀÌ»ó, ±â´ÉÀå¾Ö
  • erectile dysfunction
    ¹ß±âÀå¾Ö
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired immunodeficiency syndrome
    (¢¡AIDS) ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • dysfunction
    ±â´ÉÀå¾Ö, ±â´ÉÀÌ»ó
  • hypotonic uterine dysfunction
    ÀúÀ强Àڱñâ´ÉÀå¾Ö
  • perceptual dysfunction
    Áö°¢Àå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phagocytic cell
    Æ÷½Ä¼¼Æ÷
  • phagocytic index
    ޽İè¼ö, Æ÷½Ä¼¼Æ÷Áö¼ö
  • acquired immunodeficiency syndrome
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • constitutional hepatic dysfunction
    üÁú°£±â´ÉÀÌ»ó
  • dysfunction
    ±â´ÉÀå¾Ö, ±â´ÉÀÌ»ó
  • ejaculatory dysfunction
    »çÁ¤±â´ÉÀå¾Ö
  • erectile dysfunction
    ¹ß±â±â´ÉÀå¾Ö
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • index, phagocytic
    ޽İè¼ö
  • antiestrogen therapy, for sexual dysfunction
    Ç׿¡½ºÆ®·Î°Õ ¿ä¹ý(¼º±â´ÉÀå¾ÖÀÇ)
  • hepatic dysfunction
    °£±â´ÉÀå¾Ö(ÊÜѦÒöî¡äô)
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(¡­Ñ¦ÒöÝÕîïñøý¦ÏØ).
  • placental dysfunction syndrome
    Źݱâ´ÉºÎÀüÁõÈıº(÷ÃÚïѦÒöÝÕîïñøý¦ÏØ)
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
  • SADS, Schedule for Affective Disorders and Schizophrenia
    Á¤µ¿Àå¾Ö¿Í Á¤½ÅºÐ¿­º´ÀÇ Áø´ÜÀ» À§ÇÑ ¸ñ·Ï
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postpartum disorders
    »êÈÄ Àå¾Ö(º´)
  • psychogenic voice disorders
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • index, phagocytic
    ޽İè¼ö
  • mononuclear phagocytic system
    ´ÜÇٽO÷°è
  • mononuclear phagocytic system
    ´ÜÇÙ¼º ½Ä¼¼Æ÷°è.
  • phagocytic
    ½Ä¼¼Æ÷¼º(¡­àõ).
  • phagocytic activity
    ½Ä¼¼Æ÷´É(¡­Òö).
  • phagocytic anemia
    ½Ä¼¼Æ÷¼º ºóÇ÷(¡­Þ¸úì).
  • phagocytic immunity
    ½Ä¼¼Æ÷¼º¸é¿ª (¡­Øóæ¹).
  • phagocytic index
    ½Ä¼¼Æ÷Áö¼ö(¡­ò¦â¦).
  • phagocytic index
    ޽ĴÉÁö¼ö
  • phagocytic index
    ½Ä¼¼Æ÷Áö¼ö(¡­ò¦â¦).
  • phagocytic synovial cell
    Æ÷½ÄÀ±È°¼¼Æ÷
  • antiestrogen therapy, for sexual dysfunction
    Ç׿¡½ºÆ®·Î°Õ ¿ä¹ý(¼º±â´ÉÀå¾ÖÀÇ)
  • cardiac dysfunction
    ½É±â´ÉÀå¾Ö(ãýѦÒöî¡äô)
  • cardiac dysfunction
    ½É(Àå)±â´ÉÀå¾Ö.
  • constitutional hepatic dysfunction
    üÁú¼º °£±â´ÉÀÌ»ó(¡­ÊÜѦÒöì¶ßÈ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Phagocytic synovial cell
    Æ÷½ÄÀ±È°¼¼Æ÷
    [¿¾ ¿ë¾î] Ȱ¸·½Ä¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dysfunction
    ±â´ÉÀå¾Ö(ѦÒöî¡äô)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • ovarian dysfunction
    ³­¼Ò±â´ÉÀÌ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MPDS mandibular pain dysfunction syndrome; myofascial pain dysfunction syndrome
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MPS Mononuclear-Phagocytic-System
PI phagocytic index
HIV/AIDS Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Di Dysfunction Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • American Academy of Craniomandibualr Disorders
    ¹Ì±¹ µÎ°³ÇϾÇÀå¾ÖÇÐȸ
  • phagocytic activity
    ½Ä¼¼Æ÷´É
  • phagocytic immunity
    ½Ä¼¼Æ÷¼º ¸é¿ª
  • phagocytic synovial cell
    Æ÷½Ä À±È° ¼¼Æ÷
  • acquired immunodeficiency
    ÈÄõ¼º ¸é¿ª°áÇÌ
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¼º ¸é¿ª °áÇÌ ÁõÈıº
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª °áÇÌ Áúȯ
  • human immunodeficiency virus
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º
  • human immunodeficiency virus infection
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º °¨¿°
  • immunodeficiency
    ¸é¿ª °áÇÌ
    ¸é¿ª ¹ÝÀÀÀÇ °áÇÌÀ¸·Î ÀÎÇÑ ¸é¿ª Àå¾Ö´Â Ç×ü[B ¼¼Æ÷] ¸é¿ª °áÇÌ, ¼¼Æ÷¼º [T ¼¼Æ÷} ¸é¿ª °áÇÌ, ÇÕº´Çü ¸é¿ª °áÇÌ ¹× ½Ä ÀÛ¿ë ±â´É Àå¾Ö·Î ºÐ·ùÇÑ´Ù. Ç×ü ¸é¿ª °áÇÌÀº Àú ȤÀº ÀÌ»ó °¨¸¶ ±Û·ÎºÒ¸°Ç÷Áõ, ¹Ýº¹¼º ¼¼±Õ¼º ÁßÀÌ¿° ¹× ºÎºñµ¿ Æó¼º °¨¿°Áõ µîÀÌ Æ¯Â¡ÀÌ´Ù. ¼¼Æ÷¼º ¸é¿ª °áÇÌÀº ±âȸ °¨¿°ÀÌ ÀÚÁÖ ÀϾ°í, ¼öÇ÷ ÈÄ ÀÌ½ÄÆí ´ë ¼÷ÁÖ ¹ÝÀÀ, »ý ¹é½Å ¸é¿ª Á¢Á¾ ÈÄ ½ÉÇÑ °¨¿°ÁõÀÇ ¹ß»ý µîÀÌ Æ¯Â¡ÀÌ´Ù. ½Ä ÀÛ¿ë ±â´É Àå¾Ö´Â ¿ÜÀμº°ú ³»Àμº ¿äÀÎÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¿ÜÀμº ¿äÀÎÀº ¸é¿ª ¾ïÁ¦Á¦¿¡ ÀÇÇÑ ½Ä ¼¼Æ÷ ¼öÀÇ °¨¼Ò ȤÀº ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵忡 ÀÇÇÑ ±â´É Àå¾Ö µîÀ̸ç, ³»Àμº ¿äÀÎÀº °ü·ÃµÈ È¿¼Ò °áÇÌ µîÀ» µé ¼ö ÀÖ´Ù. ½Ä ÀÛ¿ë ±â´É Àå¾Ö´Â °æ¹ÌÇÑ ¹Ýº¹¼º ÇǺΠ°¨¿°À¸·ÎºÎÅÍ Ä¡¸íÀûÀÎ Àü½Å¼º °¨¿°¿¡ À̸£±â±îÁö ¼¼±Õ EH´Â Áø±Õ¿¡ ÀÇÇÑ °¨¿°À» ¾ß±âÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ÇÕº´Çü ¸é¿ª °áÇÌÀº Ç×ü ¸é¿ªÀ» ¸Å°³ÇÏ´Â B ¸²ÇÁ±¸¿Í ¼¼Æ÷¼º ¸é¿ªÀ» ¸Å°³ÇÏ´Â T ¸²ÇÁ±¸°¡ °áÇ̵Ǿî ÀÖ´Ù.
  • severe combined immunodeficiency
    ÁßÁõ º¹ÇÕ ¸é¿ª °áÇÌÁõ, ÁßÁõ È¥ÇÕ ¸é¿ª °áÇÌÁõ
  • cardiac dysfunction
    ½É ±â´É Àå¾Ö, ½ÉÀå ±â´É Àå¾Ö
    ½ÉÀåÀÇ ±â´ÉÀå¾Ö ¶Ç´Â ÀÌ»ó.
  • dysfunction index
    ±â´ÉÀå¾Ö Áö¼ö
    ±â´É Àå¾ÖÀÇ ½ÉÇÑ Á¤µµ¸¦ Á¤·®È­ÇÑ Ã¼°è.
  • masticatory dysfunction
    ÀúÀÛ ±â´É ÀÌ»ó
  • mechanical dysfunction
    ±â°èÀû ±â´É Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
phagocytic dysfunction immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
phagocytic <cell biology> Pertaining to or produced by phagocytes.
Origin: L. Phagedaena, Gr Phago, To eat.
(16 Dec 1997)
phagocytic index The average number of bacteria observed in the cytoplasm of polymorphonuclear leukocytes after mixing and incubating, at 37°C, 1) a suspension of washed, presumably normal leukocytes, 2) the serum to be tested for opsonin, and 3) a young culture of microorganisms that are causing disease in the patient.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
phagocytic pneumonocyte An alveolar phagocyte containing haemosiderin, carbon, or other foreign particles.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
phagocytic vesicle <cell biology> Membrane bounded vesicle enclosing a particle internalised by a phagocyte. The primary phagocytic vesicle phagosome) will subsequently fuse with lysosomes to form a secondary phagosome in which digestion will occur.
Origin: L. Phagedaena, Gr Phago, To eat.
(18 Nov 1997)
papillary muscle dysfunction Impaired function of a papillary muscle, usually due to ischemia or infarction, with resulting incompetence of the mitral valve.
Synonym: papillary muscle syndrome.
(05 Mar 2000)
ventricular dysfunction A condition in which the ventricles of the heart exhibit a decreased functionality.
(12 Dec 1998)
ventricular dysfunction, left A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall.
(12 Dec 1998)
ventricular dysfunction, right A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall.
(12 Dec 1998)
phagocyte bactericidal dysfunction Disorders in which phagocytic cells cannot kill ingested bacteria; characterised by frequent recurring infection with formulation of granulomas.
(12 Dec 1998)
phagocyte dysfunction Disorder in which the ability of the phagocyte to engulf and ingest particles may be impaired.
(05 Mar 2000)
minimal brain dysfunction An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
placental dysfunction 1. Denoting faulty development or ripening; often connoting structural and/or functional abnormalities.
2. In obstetrics, denoting an infant whose birth weight is inappropriately low for its gestational age.
3. Immature development of the placenta so that normal function does not occur.
Synonym: placental dysfunction.
(05 Mar 2000)
placental dysfunction syndrome <syndrome> Foetal malnutrition and hypoxia resulting from impaired transfer of oxygen and various nutritive materials from mother to foetus.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunodeficiency
    ¸é¿ª°á¿©(ºÎÀü) 9
  • phagocytic
  • dysfunction
    ±â´ÉÀå¾Ö;¿ª±â´É
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á